PRAX vs TYL · $7.38B cap vs P/E 89, rev $1.26B
Praxis Precision Medicines Inc (PRAX) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
PRAX currently screens at market cap $7.38B. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the PRAX and TYL stock pages for the full models.
Not investment advice.